Balaxi Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA4556
EBIT4555
Earning Per Share3847
Expenses189229
Net Profit3848
Net Profit Margin1617
Operating Profit Margin1920
Profit Before Tax4455
Dividends Per Share01
Operation Revenue234284

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
201812.6313.57424.315.90
2022-274NA89.40
2022235.75256.26198.80583.68232.60
2023002,208.94NA3,249.90
NANANANANANA
The EBITDA of Balaxi Pharma is 56 as of 2/26/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
2019202020202023
Operating Activities-2-14-146
Investing Activities-0-0-0-11
Financing Activities0181826
Others0000
Net Cash Flow-24421

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.040.240.65-1.15
2023753.811,959.09-2,546.63166.27
2023886.45-593.20-118.64174.61
202317,626.46-16,860.09-1,197.52-431.15
NANANANANA
The cash flow from Operating Activities of Balaxi Pharma is 6 as of 2/26/2024